OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2025
(2)
2026
(1)
2021
(1)
2020
(1)
2016
(1)
2014
(1)
2008
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study.
Not available
S-EPMC8493307
|
biostudies-literature
Cite
Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
Not available
S-EPMC2572070
|
biostudies-literature
Cite
Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status.
Not available
S-EPMC7176965
|
biostudies-literature
Cite
LDB1 represses fetal hemoglobin expression by enhancing BCL11A transcription.
Not available
S-EPMC12907011
|
biostudies-literature
Cite
Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.
Not available
S-EPMC3943911
|
biostudies-literature
Cite
Comparison between norepinephrine plus epinephrine and norepinephrine plus vasopressin after return of spontaneous circulation in patients with out-of-hospital cardiac arrest.
Not available
S-EPMC12008422
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets